Surmodics to Host Virtual Annual Meeting of Shareholders

Rhea-AI Summary

Surmodics, Inc. (SRDX) will hold its Annual Meeting of Shareholders on February 8, 4 p.m. CT. The virtual meeting will be led by Chair of the Board, Sue Knight, and President/CEO Gary Maharaj will provide business updates. To attend, visit www.virtualshareholdermeeting.com/SRDX24. A webcast replay will be available until February 9, 2025.

Virtual Meeting on February 8 at 4 p.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Thursday, February 8, at 4 p.m. CT (5 p.m. ET), as a virtual meeting.

Sue Knight, Chair of the Board, will lead the meeting, and Gary Maharaj, President and Chief Executive Officer, will provide a brief update on business and key strategic initiatives underway at the Company.

To attend the virtual meeting, please visit www.virtualshareholdermeeting.com/SRDX24 at least five minutes prior to the start of the meeting to log in. A webcast replay of the Annual Meeting will be available until February 9, 2025.

About Surmodics, Inc.

Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development and manufacturing capabilities. The Company’s mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240116062255/en/

Surmodics Investor Inquiries:

Jack Powell, Investor Relations

ir@surmodics.com

Source: Surmodics, Inc.

FAQ

When is Surmodics, Inc.'s Annual Meeting of Shareholders?

The Annual Meeting of Shareholders will be held on February 8 at 4 p.m. CT.

Who will lead the virtual meeting?

The virtual meeting will be led by Sue Knight, Chair of the Board.

Who will provide business updates during the meeting?

Gary Maharaj, President and Chief Executive Officer, will provide a brief update on business and key strategic initiatives.

How can shareholders attend the virtual meeting?

Shareholders can attend the virtual meeting by visiting www.virtualshareholdermeeting.com/SRDX24 at least five minutes prior to the start of the meeting to log in.

Until when will the webcast replay be available?

The webcast replay of the Annual Meeting will be available until February 9, 2025.